- Global Pharma News & Resources

Global Allergy Immunotherapy Market (2018-2022) featuring Allergy Therapeutics, ALK-Abello, Merck Group, and Stallergenes -

The "Global Allergy Immunotherapy Market (2018-2022 Edition)" report has been added to's offering.

The global allergy immunotherapy market has increased at a significant CAGR during the years 2013-2017, and projections are made that the market will rise in the next four years i.e. 2018-2022, tremendously.

The allergy immunotherapy market is expected to increase due to growth in healthcare expenditure, rising incidence of chronic diseases and increasing global pollution, etc. Yet the market faces some challenges such as, lack of treatment awareness, lack of investor confidence, anaphylaxia, huge treatment costs, etc.

The key players of the allergy immunotherapy market have been profiled with their financial information and respective business strategies.

Key Topics Covered

1. Executive Summary

2. Introduction

2.1 Allergy

2.2 History of Allergy

2.3 Diagnosis of Allergy

2.4 Nature of Allergy

2.5 Types of Allergy by Allergens

2.6 Types of Allergens

2.7 Prevention of Allergies

2.8 Allergy Immunotherapy: An Overview

3. Global Market Analysis

3.1 Global Allergy Immunotherapy Market: An Analysis

3.2 Global Allergy Immunotherapy Market: Methods of Administration Analysis

4. Regional Market Analysis

4.1 Europe Allergy Immunotherapy Market: An Analysis

4.2 The US Allergy Immunotherapy Market: An Analysis

4.3 Rest of the World Allergy Immunotherapy Market: An Analysis

5. Competitive Landscape

5.1 Global Competitive Landscape

5.2 Regional Competitive Landscape

6. Company Profiles

6.1 Allergy Therapeutics PLC

6.2 ALK-Abello

6.3 Merck Group

6.4 Stallergenes

For more information about this report visit

View source version on

Editor Details

Last Updated: 25-Oct-2018